Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK

INTRODUCTION: Patients with type 2 diabetes mellitus (T2DM) who fail to meet glycaemic control are at increased risk of diabetes complications. For patients who cannot maintain glycaemic control with oral medication, one recommended option is to add an injectable glucagon-like peptide-1 receptor ago...

Full description

Saved in:
Bibliographic Details
Published in:Drugs R D
Main Authors: Boye, Kristina S., Stein, Dara, Matza, Louis S., Jordan, Jessica, Yu, Ren, Norrbacka, Kirsi, Hassan, Syed Wasi, García-Pérez, Luis-Emilio
Format: Artigo
Language:Inglês
Published: Springer International Publishing 2019
Subjects:
Original Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6544605/
https://ncbi.nlm.nih.gov/pubmed/31115873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-019-0273-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items